Annual Retained Earnings
-$242.53 M
-$8.59 M-3.67%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual retained earnings is -$242.53 million, with the most recent change of -$8.59 million (-3.67%) on December 31, 2023.
- During the last 3 years, AMPE annual retained earnings has fallen by -$42.00 million (-20.94%).
- AMPE annual retained earnings is now -2819981.40% below its all-time high of -$8600.00, reached on December 31, 2006.
Performance
AMPE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$242.53 M
-$2.05 M-0.85%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly retained earnings is -$242.53 million, with the most recent change of -$2.05 million (-0.85%) on December 31, 2023.
- Over the past year, AMPE quarterly retained earnings has dropped by -$8.59 million (-3.67%).
- AMPE quarterly retained earnings is now -2819981.40% below its all-time high of -$8600.00, reached on December 31, 2006.
Performance
AMPE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AMPE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.7% | -3.7% |
| 3 y3 years | -20.9% | -20.9% |
| 5 y5 years | -41.8% | -41.8% |
AMPE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.4% | at low | -11.4% | at low |
| 5 y | 5-year | -31.4% | at low | -31.4% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Ampio Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$242.53 M(+3.7%) | -$242.53 M(+0.9%) |
| Sep 2023 | - | -$240.47 M(+0.5%) |
| Jun 2023 | - | -$239.24 M(+0.6%) |
| Mar 2023 | - | -$237.87 M(+1.7%) |
| Dec 2022 | -$233.94 M(+7.5%) | -$233.94 M(+1.0%) |
| Sep 2022 | - | -$231.72 M(+2.8%) |
| Jun 2022 | - | -$225.31 M(+0.9%) |
| Mar 2022 | - | -$223.24 M(+2.6%) |
| Dec 2021 | -$217.60 M(+8.5%) | -$217.60 M(+2.9%) |
| Sep 2021 | - | -$211.38 M(+1.7%) |
| Jun 2021 | - | -$207.75 M(+1.7%) |
| Mar 2021 | - | -$204.19 M(+1.8%) |
| Dec 2020 | -$200.53 M(+8.6%) | -$200.53 M(+2.4%) |
| Sep 2020 | - | -$195.91 M(+1.7%) |
| Jun 2020 | - | -$192.54 M(+1.4%) |
| Mar 2020 | - | -$189.81 M(+2.8%) |
| Dec 2019 | -$184.63 M(+8.0%) | -$184.63 M(+0.6%) |
| Sep 2019 | - | -$183.61 M(+4.1%) |
| Jun 2019 | - | -$176.39 M(-0.2%) |
| Mar 2019 | - | -$176.81 M(+3.4%) |
| Dec 2018 | -$171.00 M(-16.6%) | -$171.00 M(-0.9%) |
| Sep 2018 | - | -$172.53 M(-3.3%) |
| Jun 2018 | - | -$178.33 M(-2.5%) |
| Mar 2018 | - | -$182.95 M(-10.8%) |
| Dec 2017 | -$204.99 M(+33.9%) | -$204.99 M(+26.6%) |
| Sep 2017 | - | -$161.86 M(+2.7%) |
| Jun 2017 | - | -$157.61 M(+1.7%) |
| Mar 2017 | - | -$155.00 M(+1.3%) |
| Dec 2016 | -$153.08 M(+14.3%) | -$153.08 M(+2.2%) |
| Sep 2016 | - | -$149.72 M(+2.7%) |
| Jun 2016 | - | -$145.73 M(+3.6%) |
| Mar 2016 | - | -$140.68 M(+5.1%) |
| Dec 2015 | -$133.91 M | -$133.91 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -$123.91 M(+6.3%) |
| Jun 2015 | - | -$116.54 M(+6.7%) |
| Mar 2015 | - | -$109.19 M(+7.1%) |
| Dec 2014 | -$101.90 M(+59.8%) | -$101.90 M(+10.8%) |
| Sep 2014 | - | -$91.99 M(+11.2%) |
| Jun 2014 | - | -$82.71 M(+11.7%) |
| Mar 2014 | - | -$74.02 M(+16.1%) |
| Dec 2013 | -$63.78 M(+60.4%) | -$63.78 M(+13.0%) |
| Sep 2013 | - | -$56.44 M(+12.1%) |
| Jun 2013 | - | -$50.37 M(+14.6%) |
| Mar 2013 | - | -$43.95 M(+10.5%) |
| Dec 2012 | -$39.77 M(+41.1%) | -$39.77 M(+10.2%) |
| Sep 2012 | - | -$36.09 M(+7.7%) |
| Jun 2012 | - | -$33.51 M(+8.0%) |
| Mar 2012 | - | -$31.01 M(+10.1%) |
| Dec 2011 | -$28.18 M(+187.0%) | -$28.18 M(+17.4%) |
| Sep 2011 | - | -$23.99 M(+12.0%) |
| Jun 2011 | - | -$21.42 M(+15.2%) |
| Mar 2011 | - | -$18.60 M(+89.4%) |
| Dec 2010 | -$9.82 M(+456.3%) | -$9.82 M(+43.6%) |
| Sep 2010 | - | -$6.84 M(+55.6%) |
| Jun 2010 | - | -$4.39 M(+35.3%) |
| Mar 2010 | - | -$3.25 M(+84.0%) |
| Dec 2009 | -$1.76 M(+2334.3%) | -$1.76 M(+1801.8%) |
| Sep 2009 | - | -$92.80 K(+5.7%) |
| Jun 2009 | - | -$87.80 K(+5.7%) |
| Mar 2009 | - | -$83.10 K(+14.6%) |
| Dec 2008 | -$72.50 K(+78.6%) | -$72.50 K(+4.8%) |
| Sep 2008 | - | -$69.20 K(+14.8%) |
| Jun 2008 | - | -$60.30 K(+2.6%) |
| Mar 2008 | - | -$58.80 K(+44.8%) |
| Dec 2007 | -$40.60 K(+372.1%) | -$40.60 K(+27.7%) |
| Sep 2007 | - | -$31.80 K(+269.8%) |
| Dec 2006 | -$8600.00 | -$8600.00 |
FAQ
- What is Ampio Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual retained earnings year-on-year change?
- What is Ampio Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly retained earnings year-on-year change?
What is Ampio Pharmaceuticals annual retained earnings?
The current annual retained earnings of AMPE is -$242.53 M
What is the all time high annual retained earnings for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual retained earnings is -$8600.00
What is Ampio Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AMPE annual retained earnings has changed by -$8.59 M (-3.67%)
What is Ampio Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AMPE is -$242.53 M
What is the all time high quarterly retained earnings for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly retained earnings is -$8600.00
What is Ampio Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AMPE quarterly retained earnings has changed by -$8.59 M (-3.67%)